Taken together, we successfully isolated FAP+ cells from human GBMs that express mesenchymal markers, are non-tumorigenic, and in most cases lack genetic aberrations characteristic of glioma cells, which suggests that they are non-malignant mesenchymal cells. This evidence concerns the gene FAP and central nervous system cancer.